Overview
Cytomegalovirus (CMV) is a double-stranded DNA lytic virus belonging to the human herpesvirus group, as described in the document. CMV infection is common worldwide and often remains latent after primary infection. The virus is characterized by a cytopathic effect, with the hallmark finding being enlarged cells containing viral inclusion bodies. CMV can infect multiple cell types using different entry mechanisms, including pH-dependent endocytosis in epithelial and endothelial cells and non-endocytic entry into fibroblasts.
The CMV Virus Qualitative test is based on polymerase chain reaction (PCR) technology and is designed to detect the presence or absence of CMV DNA in clinical samples. This test does not measure viral load but confirms whether CMV genetic material is present. According to the document, it is considered an optimal test for diagnosing active CMV infection, especially in high-risk populations such as transplant recipients, neonates, and immunocompromised individuals. Early detection allows timely clinical intervention and prevention of severe complications.
Symptoms
Symptoms of CMV infection vary depending on the immune status of the patient, as outlined in the document. Many individuals may be asymptomatic, while others develop mild to severe manifestations.
Common symptoms include:
- Fever
- Headache
- Fatigue
- Muscle pain
- Jaundice
More severe manifestations may include:
- Pneumonia
- Retinitis, which may impair vision
- Hepatomegaly and splenomegaly
- Gastrointestinal tract infection
- Bronchitis
In neonates and congenital infection, symptoms may include:
- Premature delivery
- Seizures
- Hearing loss
- History of stillbirth or repeated abortions
The document emphasizes that symptoms often depend on whether the immune system is compromised or artificially suppressed, such as in post-transplant patients. CMV should be suspected when patients present with atypical clinical features or unexplained illness.
Causes
According to the document, CMV infection is caused by viral entry and replication within host cells, followed by lifelong latency. The virus can reactivate when immune surveillance is weakened.
CMV infection occurs through:
- Direct exposure to infected body fluids
- Vertical transmission from mother to fetus
- Organ transplantation
- Blood or tissue exposure
The qualitative PCR test detects specific CMV DNA sequences, confirming viral presence in specimens such as blood, bone marrow, amniotic fluid, bronchoalveolar lavage, cerebrospinal fluid, ocular fluid, urine, or dried blood spots. Detection generally becomes reliable from the second week after symptom onset, although early detection is possible due to the high sensitivity of PCR amplification.
Risk Factors
Risk factors for CMV infection and reactivation are primarily related to immune status and clinical vulnerability, as detailed in the document.
Major risk factors include:
- Organ transplantation
- Immunosuppressive therapy
- HIV infection
- Neonatal period
Additional risk factors include:
- Premature birth
- Pregnancy
- Prolonged hospitalization
- History of repeated abortions or stillbirths
- Suspected congenital infection
The document highlights that CMV qualitative testing is particularly useful for early detection in immunocompromised and transplant patients, where rapid diagnosis can prevent severe disease progression.
Prevention
There is no vaccine currently available for CMV, as stated in the document. Preventive strategies, therefore, focus on early diagnosis, monitoring, and clinical management rather than complete prevention of infection.
Preventive measures include:
- Prompt testing when CMV infection is suspected
- Early screening in high-risk individuals, such as transplant recipients and neonates
- Avoiding delays in testing, especially in hospitalized patients
From a laboratory perspective, prevention of false results relies on:
- Proper sample collection in appropriate containers
- Timely refrigeration and transport of specimens
- Avoiding repeated freeze–thaw cycles
- Adhering to recommended storage temperatures
